Human placental exosomes induce maternal systemic immune tolerance by reprogramming circulating monocytes.

Area of Science:

• Immunology
• Reproductive Biology
• Cell Biology

Background:

• Maternal immune tolerance to the semi-allogeneic fetus is crucial for successful pregnancy.
• Failure to achieve tolerance can lead to complications like pre-eclampsia and pregnancy loss.
• The systemic mechanisms regulating maternal immune tolerance remain largely unknown.

Purpose of the Study:

• To investigate the role of first-trimester placenta-derived exosomes (pEXOs) in regulating maternal systemic immune tolerance.
• To elucidate the molecular mechanisms by which pEXOs influence circulating monocytes.

Main Methods:

• Exosome isolation and characterization from first-trimester placentas.
• Monocyte isolation and treatment with pEXOs.
• Transcriptomic analysis (microRNAome and mRNA) of pEXO-treated monocytes.
• Monocyte-T-cell co-culture assays.
• Flow cytometry and functional immune cell assays.

Main Results:

• pEXOs preferentially target and reprogram circulating monocytes, inducing an immunosuppressive phenotype.
• pEXO-educated monocytes exhibit reduced activation markers and enhanced M2 polarization.
• pEXOs decrease T helper and cytotoxic T cell proliferation while increasing regulatory T cell expansion.
• pEXO-derived miR-29a-3p upregulates PD-L1 expression in monocytes by downregulating PTEN, suppressing adaptive immunity.

Conclusions:

• This study is the first to demonstrate how human pEXOs directly regulate monocyte function and mediate maternal immune tolerance in early pregnancy.
• pEXOs play a critical role in reprogramming circulating monocytes, contributing to systemic maternal immune adaptation.
• These findings provide a molecular basis for understanding maternal immune tolerance to the fetal allograft and its potential dysregulation in pregnancy complications.